Accessibility Statement


How often do you stop and think about your immune system? If you live with one of the more than 80 immune-mediated diseases, you probably think about it more than most.

Immune-mediated diseases are chronic and can have a significant impact on a person’s quality of life due to potential physical, emotional and psychological burdens. Today, four to five percent of people in the world live with an immune-mediated disease.

Even with the current treatment options that are available to treat many immune-mediated diseases, there is still a significant unmet need for people living with these diseases. That is why we aspire to deliver innovative medicines that enable breakthrough outcomes to address the unresolved impact of immune-mediated diseases.

Lilly has been able to provide immunology treatments to more than 1.5 million people around the world, but there are many more in need. That’s what motivates us to continue to find the next generation of treatments.

Understanding the Impact of Immune-mediated Diseases

Addressing Health Equity

Setting New Expectations in Immunology

Additional Resources